David Zimmerman
Cardiovascular Disease · Marietta, GANPI 1134181472
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Novartis at 24.9% of the total. Reporting peaked in 2019 at $1,318 and has fallen 95.1% since, to $65 in 2025.
Across 184 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$784
- Johnson & Johnson$305
- Amgen$297
- E.r. Squibb & Sons, L.L.C.$251
- Pfizer$196
- Heartflow, Inc.$162
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,134100%
- Entertainment$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 46 | $784 |
| Johnson & Johnson | 25 | $305 |
| Amgen | 18 | $297 |
| E.r. Squibb & Sons, L.L.C. | 20 | $251 |
| Pfizer | 12 | $196 |
| Heartflow, Inc. | 1 | $162 |
| Amarin Pharma, Inc. | 7 | $131 |
| Boehringer Ingelheim | 6 | $117 |
| Sanofi-aventis U.S. LLC | 7 | $117 |
| Esperion Therapeutics, Inc. | 7 | $117 |
| AstraZeneca | 6 | $106 |
| Boston Scientific | 5 | $100 |
| Cvrx, Inc. | 3 | $95 |
| W. L. Gore & Associates, Inc. | 4 | $85 |
| Merck | 4 | $64 |
| Bayer | 2 | $38 |
| United Therapeutics Corporation | 2 | $36 |
| Gilead | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Novo Nordisk | 1 | $23 |
| Lundbeck LLC | 1 | $18 |
| Optos, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Edwards Lifesciences | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$162
How this compares
$3,147 in reported general payments places this provider in the 55th percentile of 640 cardiovascular disease providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 96 | $96,620 |
| XareltoRivaroxaban | 24 | $31,445 |
| Rosuvastatin Calcium | 117 | $1,657 |
| Ezetimibe | 50 | $894 |
| Carvedilol | 63 | $469 |
| Lisinopril | 60 | $432 |
| Metoprolol Succinate | 42 | $423 |
| Atorvastatin Calcium | 50 | $418 |
| Nifedipine ErNifedipine | 14 | $414 |
| Torsemide | 15 | $375 |
| Losartan Potassium | 34 | $374 |
| Amlodipine Besylate | 46 | $271 |
| Pravastatin Sodium | 25 | $270 |
| Potassium Chloride | 15 | $228 |
| Furosemide | 25 | $178 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $196 | $96,62096 claims |
| Johnson & JohnsonXarelto | $305 | $31,44524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 640 cardiovascular disease providers in Georgia.
Other cardiovascular disease in Marietta
- Dhaval PatelMarietta$67K
- George KramerMarietta$55K
- Narendra SinghJohns Creek$1.6M
- Hunter ChampionColumbus$1.5M
- Nicolas ChronosEatonton$912K
- Jaime BurkleGainesville$628K
- Joseph MillerAtlanta$573K
- Kashyap ChoksiThomasville$263K
- Utpal PandyaAtlanta$221K
- Randolph MartinAtlanta$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.